(Q35134255)

6 August 2017

1 reference

title

Inflammation and emerging risk factors in diabetes mellitus and atherosclerosis (English)

1 reference

6 August 2017

1 reference

Pierre Theuma

1

1 reference

6 August 2017

Vivian A Fonseca

series ordinal

2

1 reference

6 August 2017

publication date

1 June 2003

1 reference

6 August 2017

published in

Current diabetes report

1 reference

6 August 2017

volume

3

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

248-254

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-003-0072-3

6 August 2017

exact match

0 references

cites work

Evaluating novel cardiovascular risk factors: can we better predict heart attacks?

1 reference

https://api.crossref.org/works/10.1007%2FS11892-003-0072-3

Infections, inflammation, and the risk of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-003-0072-3

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-003-0072-3

Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-003-0072-3

Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-003-0072-3

Is C-reactive protein specific for vascular disease in women?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-003-0072-3

Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-003-0072-3

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-003-0072-3

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-003-0072-3

Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-003-0072-3

Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes : 5-year follow-up of the Hoorn Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-003-0072-3

Vascular thrombosis in type II diabetes mellitus

21 January 2018

1 reference

12 December 2020

Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women

1 reference

12 December 2020

Hyperhomocysteinemia and the endocrine system: implications for atherosclerosis and thrombosis

1 reference

12 December 2020

Plasma homocysteine concentrations are regulated by acute hyperinsulinemia in nondiabetic but not type 2 diabetic subjects.

1 reference

12 December 2020

Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies

1 reference

12 December 2020

Plasma homocysteine and all-cause mortality in diabetes

1 reference

12 December 2020

Weight loss reduces C-reactive protein levels in obese postmenopausal women

1 reference

12 December 2020

Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials

1 reference

12 December 2020

Prevalence of clinical and isolated subclinical cardiovascular disease in older adults with glucose disorders: the Cardiovascular Health Study

1 reference

12 December 2020

Association between C-reactive protein and features of the metabolic syndrome: a population-based study

1 reference

12 December 2020

Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial

1 reference

12 December 2020

Treatment of mild hyperhomocysteinemia in vascular disease patients

1 reference

12 December 2020

Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes

1 reference

12 December 2020

Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men

1 reference

12 December 2020

Mechanical strain induces specific changes in the synthesis and organization of proteoglycans by vascular smooth muscle cells

1 reference

12 December 2020

Drugs affecting homocysteine metabolism: impact on cardiovascular risk

1 reference

12 December 2020

Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study

1 reference

12 December 2020

Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines

1 reference

12 December 2020

Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease

1 reference

12 December 2020

The NF-kappa B and I kappa B proteins: new discoveries and insights

1 reference

12 December 2020

Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups.

1 reference

12 December 2020

The effect of troglitazone on plasma homocysteine, hepatic and red blood cell S-adenosyl methionine, and S-adenosyl homocysteine and enzymes in homocysteine metabolism in Zucker rats

1 reference

12 December 2020

Inflammation and atherosclerosis: the value of the high-sensitivity C-reactive protein assay as a risk marker

1 reference

12 December 2020

The effect of glucose and insulin on the activity of methylene tetrahydrofolate reductase and cystathionine-beta-synthase: studies in hepatocytes

1 reference

12 December 2020

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

1 reference

12 December 2020

Inflammation and atherosclerosis

1 reference

12 December 2020

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

1 reference

12 December 2020

Elevated C-reactive protein levels in overweight and obese adults

1 reference

12 December 2020

Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial

1 reference

12 December 2020

Nuclear factor-kappaB suppressive and inhibitor-kappaB stimulatory effects of troglitazone in obese patients with type 2 diabetes: evidence of an antiinflammatory action?

1 reference

12 December 2020

Shouldering the Risk Factor Burden

1 reference

12 December 2020

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

1 reference

12 December 2020

Hyperhomocysteinemia following a methionine load in patients with non-insulin-dependent diabetes mellitus and macrovascular disease

1 reference

12 December 2020

Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells

1 reference

12 December 2020

Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.

1 reference

12 December 2020

C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study

1 reference

12 December 2020

Clinical efficacy of an automated high-sensitivity C-reactive protein assay.

1 reference

12 December 2020

Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study

1 reference

12 December 2020

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

1 reference

12 December 2020

The pathogenesis of atherosclerosis: a perspective for the 1990s

1 reference

12 December 2020

T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein

1 reference

12 December 2020

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

12 December 2020

Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Plasma homocysteine concentration, statin therapy, and the risk of first acute coronary events

1 reference

12 December 2020

The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm

1 reference

12 December 2020

Diabetes and decline in heart disease mortality in US adults.

1 reference

12 December 2020

10.1007/S11892-003-0072-3

Identifiers

DOI

1 reference

6 August 2017

1 reference